Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
NTC grants to Zhaoke exclusive license and distribution rights in Asia for NTC014, innovative drug for bacterial conjunctivitis 2021-01-08 20:55
Atsushi Sugita Succeeds Koichi Takagi as President & CEO of Maruho 2021-01-08 14:00
IACTA Pharmaceuticals and Pharmaleads to Develop the World's First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain 2021-01-07 20:00
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18 2021-01-06 21:00
RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation for NTM Disease 2021-01-06 20:24
Yiling Pharma expects to double its YoY net profit in 2020 2021-01-06 16:55
Connect Biopharma Establishes Scientific Advisory Board Comprised of Clinical Development and Program Indication Experts 2021-01-05 21:00
Chiauranib, an Anti-tumor Drug Developed by Chipscreen, is Given CDE "Breakthrough Therapy Designation" 2021-01-05 17:49
Antengene Announces Submission of IND Application in China for a Global Phase 3 Trial of ATG-010 (Selinexor) in Advanced or Recurrent Endometrial Cancer 2021-01-05 08:00
AGC Biologics Confirms Cell and Gene Therapy Commercial Expertise as Manufacturer of Orchard Therapeutics' Newly Approved Libmeldy(TM) 2021-01-04 22:30
INOVIO and Advaccine Announce Exclusive Partnership To Commercialize COVID-19 DNA Vaccine Candidate, INO-4800, in Greater China 2021-01-04 21:00
Antengene Submits NDA for ATG-010 (Selinexor) in South Korea for rrMM and rrDLBCL 2021-01-04 08:00
RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib 2020-12-31 22:38
WinHealth and Immedica enter agreement giving Winhealth rights to Ravicti® in China and several other Asia-Pacific countries 2020-12-31 09:00
Modern Chinese Medicine Group Co., Ltd. to raise a maximum of approximately HK$221 million by way of Public Offer and Placing 2020-12-30 23:38
Insilico enters into a collaboration with APRINOIA to apply novel generative AI-powered system to discover novel compounds for neurodegenerative diseases 2020-12-30 10:29
WuXi Biologics Receives GMP Certification from Brazil's ANVISA 2020-12-28 17:50
First Subject Dosed with Gannex's FXR Agonist ASC42 in a U.S. Phase I Trial 2020-12-28 08:30
Innovent Announces the NMPA Granted New Indication Approval for BYVASDA® (Bevacizumab Biosimilar) for the Treatment of Adult Recurrent Glioblastoma 2020-12-28 08:00
INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet's EClinicalMedicine 2020-12-24 23:12
1 138 139 140 141 142 234